Gosset Cytochrome bc1 complex Overview
The **cytochrome bc1 complex** (also known as ubiquinol-cytochrome c reductase or Complex III) is a multi-subunit enzyme complex essential for the electron transport chain in mitochondria, as well as in many bacteria and protozoa. It catalyzes the transfer of electrons from ubiquinol to cytochrome c and couples this process to proton translocation across membranes, generating a proton gradient that drives ATP synthesis. In protozoa, this complex is structurally and functionally homologous to the mammalian enzyme, but modest sequence differences can be exploited for selective drug targeting. Inhibition of the protozoan cytochrome bc1 complex leads to the collapse of the mitochondrial proton gradient, disrupts ATP production, and can result in cellular death, making it a validated therapeutic target in infectious diseases such as malaria, toxoplasmosis, and other protozoal infections. The bc1 complex is comprised of multiple subunits, including cytochrome b, cytochrome c1, and the Rieske iron-sulfur protein, with two key quinone binding sites (Qo and Qi) that are targeted by various drugs and inhibitors[1][2][3][5][6][7].
Mechanism of Action
Inhibition of electron transport by binding to ubiquinone/quinol binding sites Disruption of proton motive force and ATP generation Induction of oxidative stress in pathogens (via superoxide production for some inhibitors)
Biological Functions
Disease Associations
Safety Considerations
- Off-target inhibition of mammalian mitochondrial bc1 (potential mitochondrial toxicity)
- Development of resistance mutations in protozoan pathogens
- Generation of reactive oxygen species (ROS) under some conditions
Interacting Drugs
Associated Biomarkers
| Biomarker |
|---|
| Mutations in cytochrome b gene (for drug resistance monitoring in pathogens) |
| Expression/activity levels in mitochondrial disorders (research setting) |